Latest news

Thumbnail image for Gov’t to introduce tech standards for the NHS

Gov’t to introduce tech standards for the NHS

Health secretary Matt Hancock has unveiled his vision for technology in healthcare, which, he claims, will lay the foundation for a new generation of digital services able to meet the needs of clinicians, patients and managers.

18th October 2018

Thumbnail image for NHS green light for Novartis skin cancer combo

NHS green light for Novartis skin cancer combo

The NHS now has three months to ensure that Novartis’ combination therapy dabrafenib/trametinib is routinely available to eligible skin cancer patients, after cost regulators published guidance backing funds for the treatment.

18th October 2018

Thumbnail image for Novartis buys Endocyte for $2.1 billion

Novartis buys Endocyte for $2.1 billion

Novartis has signed a deal to acquire US biopharma Endocyte, securing itself access to novel radiopharmaceutical programmes “with significant sales potential”.

18th October 2018

Thumbnail image for Another Humira biosimilar hits EU shores

Another Humira biosimilar hits EU shores

Samsung Bioepis has announced the European launch of Humira biosimilar Imraldi, as NHS chiefs tell Trusts to ensure they are ready to realise the potential savings from using cheaper versions of the world’s biggest selling drug.

17th October 2018

Thumbnail image for Pfizer’s Talzenna cleared for breast cancer

Pfizer’s Talzenna cleared for breast cancer

US regulators have approved Pfizer’s PARP inhibitor Talzenna to treat patients with breast cancer carrying a certain mutation, identified by a companion diagnostic developed by Myriad.

17th October 2018

Previous  --   17 18 19 20 21 22 23 24 25 26   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download